Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.2K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

1.8K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

826
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
826
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

948
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
948

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Effects of Radioiodine on the Nasolacrimal System.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2022
Same author

Thyroid Abnormalities in Heart Failure.

Cardiology clinics·2022
Same author

Hypothyroid Symptoms in Levothyroxine-Treated Patients.

Innovations in pharmacy·2021
Same author

Thyroid Abnormalities in Heart Failure.

Heart failure clinics·2019
Same author

Assessment of the Adequacy of Thyroid Hormone Replacement Therapy in Hypothyroidism.

Frontiers in endocrinology·2019
Same author

Thyroid Hormones and Cardiovascular Function and Diseases.

Journal of the American College of Cardiology·2018

相关实验视频

Updated: May 3, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.4K

甲状腺疾病和心脏.

Irwin Klein1, Sara Danzi

  • 1Department of Medicine and the Feinstein Institute for Medical Research, North Shore University Hospital, 350 Community Dr, Manhasset, NY 11030, USA. iklein@nshs.edu

Circulation
|October 10, 2007
PubMed
概括

甲状腺疾病显著影响心血管健康,导致心脏功能和血压发生变化. 恢复正常的甲状腺水平往往可以逆转这些有害影响.

科学领域:

  • 心脏病学 心脏病学
  • 内分泌学 在内分泌学.
  • 甲状腺学 甲状腺学

背景情况:

  • 甲状腺功能障碍,包括甲状腺功能过高和甲状腺功能低下,深刻影响心血管功能.
  • 了解甲状腺激素作用的细胞机制解释了心血管变化,如心脏输出,收缩率,血压,血管抵抗和心律失常的改变.
  • 识别甲状腺疾病对心脏的影响至关重要,因为正常化甲状腺功能通常会逆转血液动力学异常.

研究的目的:

  • 审查甲状腺疾病的心血管表现.
  • 讨论诊断甲状腺功能测试和治疗,以实现一个euthyroid状态.
  • 在心力衰竭和阿米奥达龙诱导的甲状腺功能障碍中检查甲状腺激素代谢.

主要方法:

  • 文献综述侧重于细胞机制,临床发现,诊断测试和甲状腺疾病相关心血管问题的治疗.
  • 在慢性心力衰竭中分析甲状腺激素代谢.
  • 对阿米奥达龙诱导的甲状腺功能障碍的管理策略的审查.

主要成果:

  • 甲状腺功能障碍导致显著的心血管变化,包括心脏输出,收缩性,血压和心律的改变.
  • 适当的甲状腺功能测试有助于诊断,治疗以恢复甲状腺状况可以逆转心血管异常.
  • 慢性心力衰竭会改变甲状腺激素代谢,而阿米奥达龙的使用可以诱导甲状腺功能测试异常,需要特殊的管理.

更多相关视频

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.0K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

750

相关实验视频

Last Updated: May 3, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
06:39

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders

Published on: August 18, 2016

16.4K
Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders
05:58

Testing Acetylcholine Followed by Adenosine for Invasive Diagnosis of Coronary Vasomotor Disorders

Published on: February 3, 2021

4.0K
Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

750

结论:

  • 甲状腺疾病的心血管影响是显著的,并且在适当的治疗下是可逆的.
  • 通过甲状腺功能测试进行准确的诊断,并实现平衡甲状腺状态是管理这些疾病的关键.
  • 对于心力衰竭和阿米奥达龙使用中的甲状腺功能障碍需要特别考虑.